P

Inventor

ELOKDAH HASSAN MAHMOUD

US28 patents
⚠️ This page may combine multiple inventors who share the name “ELOKDAH HASSAN MAHMOUD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WYETH CORP

23 patents
US6800654B2Oct 5, 2004

Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)

WYETH CORP75 citations96
US7074817B2Jul 11, 2006

Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)

WYETH CORP17 citations90
US6589970B2Jul 8, 2003

6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)

WYETH CORP20 citations89
US7101903B2Sep 5, 2006

Substituted dihydropyrano indole-3,4-dione derivatives as inhibitiors of plasminogen activator inhibitor-1 (PAI-1)

WYETH CORP13 citations84
US7056943B2Jun 6, 2006

Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)

WYETH CORP12 citations83
US7351730B2Apr 1, 2008

Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)

WYETH CORP11 citations82
US6939886B2Sep 6, 2005

Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1)

WYETH CORP8 citations72
US6599925B2Jul 29, 2003

Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)

WYETH CORP12 citations72
US7411064B2Aug 12, 2008

1-Heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands

WYETH CORP3 citations62
US7351726B2Apr 1, 2008

Substituted oxadiazolidinediones

WYETH CORP3 citations62
US7291639B2Nov 6, 2007

Aryloxy-acetic acid compounds useful as inhibitors of plasminogen activator inhibitor-1 (PAI-1)

WYETH CORP5 citations62
US7057039B2Jun 6, 2006

1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands

WYETH CORP4 citations62
US7420083B2Sep 2, 2008

Substituted aryloximes

WYETH CORP3 citations61
US7342039B2Mar 11, 2008

Substituted indole oximes

WYETH CORP4 citations61
US7259182B2Aug 21, 2007

Aryl, aryloxy, and aklyloxy substituted 1H-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)

WYETH CORP3 citations61
US7163954B2Jan 16, 2007

Substituted naphthyl benzothiophene acids

WYETH CORP2 citations61
US7534894B2May 19, 2009

Biphenyloxy-acids

WYETH CORP6 citations60
US7414051B2Aug 19, 2008

Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands

WYETH CORP2 citations59
US7501421B2Mar 10, 2009

Benzoxazole and benzothiazole derivatives as 5-hydroxytryptamine-6 ligands

WYETH CORP1 citations52
US7629377B2Dec 8, 2009

Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)

WYETH CORP0 citations51
US7446201B2Nov 4, 2008

Substituted heteroaryl benzofuran acids

WYETH CORP1 citations51
US7482461B2Jan 27, 2009

Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands

WYETH CORP0 citations49
US7429582B2Sep 30, 2008

Dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands and use thereof in the treatment of attention deficit disorders

WYETH CORP0 citations38

WYETH LLC

3 patents

AMERICAN HOME PROD

1 patent

ELOKDAH HASSAN MAHMOUD

1 patent